Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1167557 Greenwich, CT
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,494,204
+$170,857 QoQ
Shares Held
963,014
+27.2% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. AVXL ranks #117 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in AVXL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,494,204 963,014
2026-03-31 $2,323,347 756,792
2025-12-31 $533,338 149,815
2025-09-30 $249,519 28,036
2025-06-30 $267,960 29,063
2025-03-31 $250,027 29,141
2024-12-31 $518,902 48,315
2024-09-30 $776,137 136,644
2024-06-30 $190,823 45,219
2024-03-31 $93,645 18,398
2023-12-31 $173,175 18,601
2023-09-30 $109,987 16,792
2023-06-30 $108,397 13,333
2023-03-31 $106,619 12,441
2022-12-31 $235,000 25,378
2022-09-30 $265,956 25,771
2022-06-30 $243,263 24,302
2022-03-31 $349,837 28,419
2021-12-31 $632,563 36,480
2021-09-30 $549,736 30,626
2021-06-30 $667,397 29,195
2021-03-31 $424,864 28,419
2020-12-31 $214,012 39,632
2020-09-30 $172,617 37,938
2020-06-30 $177,193 36,015
2020-03-31 $64,760 20,559